Royal Agrifirm Group completes acquisition of Hamlet Protein
Apeldoorn, The Netherlands, 1 May 2026 – Royal Agrifirm Group today announces the successful completion of its acquisition of Hamlet Protein, a global leader in specialty soy‑based protein ingredients for young animal nutrition.
With the transaction now closed, Hamlet Protein becomes part of Royal Agrifirm Group’s Specialties business. The acquisition further strengthens Agrifirm’s portfolio of high-value nutritional solutions and its strategic focus on early-life nutrition.
Bas van Driel, Group Director Specialties at Royal Agrifirm Group, commented: “With the transaction now completed, we are pleased to welcome Hamlet Protein to our company. This step strengthens our Specialties business and our ability to support our valued customers with differentiated, science-based nutritional solutions.”
Hamlet Protein is internationally recognized for its highly digestible soy-based ingredients that support gut health and consistent early-life performance. Its patented processing technology and strong quality standards complement Royal Agrifirm Group’s nutritional expertise, scientific capabilities, and global market presence.
About Royal Agrifirm Group
With more than 3.000 dedicated employees driven to excel every day, Royal Agrifirm Group contributes to a responsible food chain for future generations. The company delivers measurable, relevant and sustainable value to farm, field and industry level. Founded over 130 years ago in the Netherlands, Royal Agrifirm Group is now a leading agricultural cooperative with an international network of subsidiaries within Europe, South America, USA and Asia and a worldwide distribution network.
About HAMLET PROTEIN
